Parizad et al., 2025)
Medical weight loss is one of the most effective interventions for prediabetes and insulin resistance
Clinical impact of Tirzepatide on patients with OSA and obesity
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 diabetes mellitus (T2DM) and obesity.[1] This class of medications assists in lowering blood sugar levels and promotes weight loss
LegitScript verified Active members: 150,000+ The full medication menu includes compounded semaglutide and tirzepatide injections, GLP-1 liquid drops, GLP-1 lozenges, oral semaglutide liposomal tablets, the FDA-approved Foundayo pill, brand-name Wegovy and Zepbound, plus several non-GLP-1 weight-loss medications like metformin, naltrexone-bupropion, and topiramate combinations
Ozempic a diabetes medication popular among celebrities for weight loss benefits is classified as a GLP-1 agonist